… In this study, erlotinib microparticles (ERL MPs) and erlotinib solid dispersions (ERL SDs) …
Fourier transform infrared spectroscopy (FT-IR) showed that there was a hydrogen bond …

… with increasing concentrations of Erlotinib over an extended period of time, we produced
HCC-827-derived cells which had acquired over 400-fold reduced sensitivity to Erlotinib (EC 50 …

… A spectroscopic study on the interaction between the anticancer drug erlotinib and human
serum albumin. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 78(1-4), 405–…

… Erlotinib (Ertb), is an FDA approved drug for treating lung cancer as a monotherapy and/or
in combination therapy with gemcitabine. However, clinical studies showed that long term use …

… Recent studies of signaling networks point out that an order of drugs to be administrated
to … of recalcitrant metastatic and drug-resistant cell types. In this study, a development of a …

… drug from these nanoparticles. The effects of surface modification by mAb on the release of
erlotinib … Fickian diffusion was elucidated to be the main mechanism of release of erlotinib …

… erlotinib together with their anticancer activity studies against erlotinib-sensitive A549 and
H1395 as well as erlotinib… Studies showed that extend of anticancer activity is mainly related to …

… For this study, EGFR Kinase–Erlotinib complex conformations were generated through the
MD trajectories at equal intervals. Through these extensive free energy calculations, we found …

… This study developed a method for the simultaneous determination of erlotinib and its … The
m/z values of the precursor and product ions for the analytes were as follows: erlotinib, 394.2/…

… -loaded liposomal complexes, all formulations were centrifuged to separate the insoluble
free drug. The precipitate was analyzed by UV/Vis spectroscopy at 352 nm. The entrapment …